Ares Capital Management does not own any shares in Telomir Pharmaceuticals (TELO). The owners of Ares Capital Markets Group have been compensated Twenty Five-Thousand Dollars Cash ($25,000) via bank wire transfer from a third party (Spark Newswire) for a two day Marketing Program regarding TELO with a start date of 05/30/2024 - 05/31/2024